{"id":941564,"title":"NACI Rapid Response: Updated guidance on Imvamune in ongoing monkeypox outbreaks, CCDR 48(11/12) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-10","captureTimestamp":"2026-03-10T19:32:43.624000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-11-12-november-december-2022/naci-rapid-response-updated-guidance-imvamune-ongoing-monkeypox-outbreak.html","snippet":"NACI updated guidance on Imvamune in ongoing monkeypox outbreaks Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 48-11/12, November/December 2022: Antimicrobial Use and Stewardship Date published: November/December 2022 ISSN:…","rawSnapshotUrl":"/api/snapshots/raw/941564","browseUrl":"https://replay.healtharchive.ca/job-7/20260310193243/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-11-12-november-december-2022/naci-rapid-response-updated-guidance-imvamune-ongoing-monkeypox-outbreak.html#ha_snapshot=941564","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}